|
Volumn 27, Issue 2, 2001, Pages 217-218
|
Fatal sepsis due to Mycobacterium tuberculosis after allogeneic bone marrow transplantation
a a a a |
Author keywords
Bone marrow transplantation; Graft versus host disease; Mycobacterium tuberculosis; Sepsis
|
Indexed keywords
ANTILEUKEMIC AGENT;
ASPARAGINASE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
CYTARABINE;
ETHAMBUTOL;
IMMUNOSUPPRESSIVE AGENT;
ISONIAZID;
METHOTREXATE;
MITOXANTRONE;
PYRAZINAMIDE;
RIFAMPICIN;
STREPTOMYCIN;
THYMOCYTE ANTIBODY;
TUBERCULOSTATIC AGENT;
ACUTE LYMPHOCYTIC LEUKEMIA;
ADULT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ARTICLE;
BLOOD CULTURE;
CASE REPORT;
CAUSE OF DEATH;
CLINICAL FEATURE;
DIAGNOSTIC TEST;
DISEASE SEVERITY;
FATALITY;
FEVER;
HUMAN;
LUNG LAVAGE;
MALE;
MULTIPLE ORGAN FAILURE;
MYCOBACTERIOSIS;
MYCOBACTERIUM TUBERCULOSIS;
PHILADELPHIA 1 CHROMOSOME;
PRIORITY JOURNAL;
SEPSIS;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADULT;
BONE MARROW TRANSPLANTATION;
FATAL OUTCOME;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE;
MALE;
MYCOBACTERIUM TUBERCULOSIS;
TRANSPLANTATION, HOMOLOGOUS;
TUBERCULOSIS;
|
EID: 0035135112
PISSN: 02683369
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bmt.1702737 Document Type: Article |
Times cited : (22)
|
References (5)
|